Clinical Trial Update: Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, and efficacy of asunaprevir combined with daclatasvir in HIV-HCV coinfected subjects. The trial is completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daclatasvir (daclatasvir)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: HIV-HCV | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13